Unicycive Therapeutics In... (UNCY)
NASDAQ: UNCY
· Real-Time Price · USD
4.62
0.00 (0.00%)
At close: Oct 03, 2025, 3:59 PM
4.51
-2.38%
After-hours: Oct 03, 2025, 07:13 PM EDT
0.00% (1D)
| Bid | 3.41 |
| Market Cap | 81.6M |
| Revenue (ttm) | 568K |
| Net Income (ttm) | -31.5M |
| EPS (ttm) | -2.74 |
| PE Ratio (ttm) | -1.69 |
| Forward PE | 0.39 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.84 |
| Volume | 348,821 |
| Avg. Volume (20D) | 495,249 |
| Open | 4.62 |
| Previous Close | 4.62 |
| Day's Range | 4.50 - 4.79 |
| 52-Week Range | 3.40 - 11.00 |
| Beta | 1.86 |
| Ex-Dividend Date | n/a |
About UNCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol UNCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for UNCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsUnicycive Therapeutics Inc. is scheduled to release its earnings on
Nov 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-29.85%
Unicycive Therapeutics shares are trading lower af...
Unlock content with
Pro Subscription
3 months ago
-8.89%
Unicycive Therapeutics shares are trading lower after the company announced a 1-for-10 reverse stock split effective June 20, 2025.
1 month ago · businesswire.com
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES--(BUSINESS WIRE)---- $UNCY--UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm.
